SAVE Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Safe Authorization for Vaccines during Emergencies Act or the SAVE Act
This bill imposes requirements related to the emergency authorization of a vaccine during a declared public health emergency.
If a sponsor of a product seeks Food and Drug Administration (FDA) authorization to use the product as a vaccine to address the threat causing the declared public health emergency, both the FDA and the product sponsor must meet with, and present product-related data and information to, the Vaccines and Related Biological Products Advisory Committee. The Department of Health and Human Services may make an exception to this requirement if convening a meeting would not be in the public interest.
To receive an emergency authorization, the product sponsor must agree to seek FDA market approval for the vaccine within a certain time period.
After an emergency authorization, the Advisory Committee on Immunization Practices shall report recommendations regarding the vaccine to Congress and the Centers for Disease Control and Prevention.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4427: SAVE Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-4427/
"S. 4427: SAVE Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-4427/.
S. 4427, 116th Cong. (2026), https://openamerica.io/bill/116-S-4427/.
[S. 4427: SAVE Act](https://openamerica.io/bill/116-S-4427/)